Johnson & Johnson will pay up to $3.33 billion to acquire Ollin Biosciences, advancing treatments for serious eye diseases.
The FDA is now requiring safety labeling changes on GLP-1 drugs, citing a potential increased risk of a rare eye condition.
South Jersey Gas highlights utility bill assistance and energy efficiency programs to help New Jersey households lower energy ...
Crow Holdings Development and PGIM start construction on a 3.7 million-square-foot Class A industrial campus in Logan ...
Magnolia Bakery opens its first New Jersey location in Mount Laurel, with plans for additional stores including one in Jersey ...
Tommy’s Tavern + Tap has enhanced its pizza quality by switching to Bacio cheese, reducing complaints and boosting customer ...
Reich Asset Management commits $25,000 to Rowan University to support financial planning students at the Rohrer College of ...
Regal Intel in Warren received $65,000 from NORD to study rare genetic conditions using its NeuSymbol technology to improve ...
Dentons US has named Timothy J. O’Driscoll a Litigation partner in Short Hills, NJ. An experienced trial and appellate lawyer ...
Dentons US has named Sandra Jones a partner in its Litigation practice in Short Hills, NJ. Jones advises insurers on complex ...
Lawyer.com CEO Colleen Joyce discusses the Basking Ridge company's growth, AI tools, legal marketing and expanding attorney ...
Seeger Weiss co-founder Christopher Seeger reflects on mass tort cases, corporate accountability and major litigation shaping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results